Found: 7
Select item for more details and to access through your institution.
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1033, doi. 10.1007/s00262-008-0620-4
- By:
- Publication type:
- Article
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 3, p. 277, doi. 10.1007/s00262-005-0061-2
- By:
- Publication type:
- Article
Immunotherapeutic potential of whole tumour cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 351, doi. 10.1007/s00262-002-0286-2
- By:
- Publication type:
- Article
Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0188228
- By:
- Publication type:
- Article
Sodium accumulation in breast cancer predicts malignancy and treatment response.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A novel murine model of allogeneic vaccination against renal cancer.
- Published in:
- BJU International, 2008, v. 101, n. 9, p. 1165, doi. 10.1111/j.1464-410X.2008.07532.x
- By:
- Publication type:
- Article
Enhanced cross-priming of naive CD8<sup>+</sup> T cells by dendritic cells treated by the IMi Ds<sup>®</sup> immunomodulatory compounds lenalidomide and pomalidomide.
- Published in:
- Immunology, 2013, v. 139, n. 3, p. 377, doi. 10.1111/imm.12087
- By:
- Publication type:
- Article